There are three broad groups of non-Aspergillus moulds: the mucormycetes, the hyalohyphomycetes and the phaeohyphomycetes. Infections with these pathogens are increasingly reported, particularly in the context of increasing use of immunosuppressant agents and improved diagnostics. The epidemiology of non-Aspergillus mould infections varies with geography, climate and level of immunosuppression. Skin and soft-tissue infections are the predominant presentation in the immunocompetent host and pulmonary and other invasive infections in the immunocompromised host. The more common nonAspergillus moulds include Rhizopus, Mucor, Fusarium and Scedosporium species; however, other emerging pathogens are Rasamsonia and Verruconis species, which are discussed in this article. Outbreaks of non-Aspergillus mould infections have been increasingly reported, with contaminated medical supplies and natural disasters as common sources. Currently culture and other conventional diagnostic methods are the cornerstone of diagnosis. Molecular methods to directly detect and identify mould pathogens in tissue and body fluids are increasingly used. A.P. Douglas, CMI 2016;22:670 Crown
Introduction
Non-Aspergillus filamentous fungal (or mould) infections are increasingly reported. Factors that may contribute to the emergence of these infections include increasing use of immunosuppressant agents, selection for these moulds in the setting of current antifungal prophylaxis, better recognition of these infections due to improvements in mould identification, increasing construction work and natural disasters [1e4] . The epidemiology of non-Aspergillus mould infections may be changing and better understanding of this and the appreciation of geographical or regional differences is important to inform guidelines for management of such infections.
This article aims to provide an overview of invasive fungal disease due to non-Aspergillus moulds with particular focus on the epidemiology and diagnosis of infections due to previously uncommon, and emerging moulds of clinical interest. Three broad groups of pathogens are discussed: the mucormycetes (order Mucorales), the hyalohyphomycetes and the phaeohyphomycetes, focusing on emerging pathogens as outlined in Table 1 .
Mucormycetes
Mucormycetes include the order Entomophthorales, which are discussed in another article of this special edition, and the Mucorales, which we will focus on in this section. As a group, the Mucorales are the most common cause of non-Aspergillus mould infection in humans [5, 6] and are reported to have increased in incidence in some countries such as France and Switzerland [4, 7] . However, their incidence in other regions is uncertain.
The epidemiology of mucormycosis varies with geographic region [5,7e10] . Rhizopus species are consistently the most commonly identified mucormycete in human infection [5, 11] . The second most common cause of human infection varies between studies [11] but predominant groups are Mucor and Rhizomucor, and Lichtheimia (formerly known as Absidia and Mycocladus), the last of which is more frequent in European studies [12, 13] .
Infection follows inhalation, ingestion or percutaneous inoculation of spores [14] . Risk factors for infection are similar for all types of Mucorales and include haematological malignancy with or without haematopoietic stem cell transplantation (HSCT), prolonged neutropenia or corticosteroid use, poorly controlled type 2 diabetes mellitus (DM) and trauma [9, 12, 15] . In developed countries, the predominant risk factor is haematological malignancy, with pulmonary infection the key manifestation. In developing countries such as India, rhino-orbital-cerebral mucormycosis (ROCM) in uncontrolled DM predominates [10, 15] . Soft tissue infection is the third most common manifestation and can be seen in both immunocompromised and immunocompetent individuals [15] . In immunocompromised hosts, there is a tendency for angioinvasion with subsequent dissemination [16] , although recovery from blood culture is rare. Mucorales infections are generally associated with high morbidity and mortality [11] , with the possible exception of skin and soft tissue infections in immunocompetent individuals.
Apophysomyces and Saksenaea species
Apophysomyces species are emerging pathogens, with Apophysomyces elegans by far the predominant species causing infection, mostly in the context of trauma with necrosis of soft tissue and muscle [10] . These soft-tissue infections can be rapidly progressive in both the immunocompetent and immunocompromised patient with significant mortality rates despite amphotericin B treatment and debridement. The majority of cases are reported from warm climates in the USA and India. Apophysomyces elegans is the second most common agent of mucormycosis in India [10] . Most of the reports of A. elegans soft-tissue infections in the literature are in immunocompetent hosts (74%). Survival in immunocompetent patients was similar to that in immunocompromised patients, with a significant mortality in both groups (24% mortality versus 30%). The second most common presentation is ROCM [17] , with rare reports of renal mucormycosis, usually in the context of dissemination [18] .
Notably, outbreaks of infection have followed natural disasters, well illustrated by the cluster of Apophysomyces trapeziformis softtissue infections following a tornado in Joplin, USA (see Outbreaks section). Infection caused by more uncommon Apophysomyces species include eight case reports of Apophysomyces variabilis infections, all of necrotizing soft-tissue infection [19, 20] , and one case of a novel species Apophysomyces mexicanus with soft-tissue infection following traumatic inoculation [21] .
Saksenaea vasiformis is a complex of species that includes Saksenaea oblongispora and Saksenaea erythrospora [22] . Saksenaea vasiformis infections are emergent worldwide [5,13,22e24] , with cases predominantly occurring in tropical and subtropical climates [25] . As for Apophysomyces spp., most infections follow traumatic inoculation and mechanisms of percutaneous introduction such as tattoos, intramuscular injections and vascular catheters [25e27] . In a recent study of cases of invasive mucormycosis across Australian hospitals, 5.4% of all Mucorales infections were due to Saksenaea spp. and 50% of these were in immunocompetent hosts following trauma [28] . In a review of reported Saksenaea infections, over 80% of cases of infection affected immunocompetent individuals [29] . Most infections involve the skin and soft tissue [29] with rare reports of ROCM in patients with diabetes [30] . Pulmonary, renal and disseminated infections occur in both immunocompetent and immunosuppressed patients [31e34].
Syncephalastrum spp.
Reports of Syncephalastrum racemosum infection remain rare with skin and soft tissue, ROCM and pulmonary manifestations described from diverse geographic locations (Table 2 ). The majority of cases appear to follow traumatic inoculation but have also occurred in immunocompromised hosts.
Hyalohyphomycetes
The hyalohyphomycetes, or hyaline moulds, are filamentous fungi characterized by a lack of pigmentation, with branching septate hyphae that can be difficult to distinguish from Aspergillus microscopically. They include the relatively more common genera of Fusarium and Scedosporium, as well as many previously rare but now emerging fungi such as Paecilomyces, Acremonium, Schizophyllum and Rasamsonia. These organisms are ubiquitous in the environment, found in soil, plant material and water; some are associated with infections in particular host groups or clinical settings, e.g. Rasamsonia in cystic fibrosis patients [43] (see below).
Fusarium spp.
In US and European populations, Fusarium is the second most common non-Aspergillus mould causing human infection [44, 45] ; however, studies from Australia have found Scedosporium to be more common than Fusarium [5] .
More than 50 species of Fusarium have been identified but only a few cause human infection [46] . Members of the Fusarium solani species complex are the most common pathogenic species, causing 50% of infections, followed by those of the Fusarium oxysporum species complex (~20%) and Fusarium verticillioidis and Fusarium moniliforme (~10% each) [46] . The principal portal of entry is considered to be the airways, followed by the skin at site of tissue breakdown or onychomycosis. Patients at high risk of fusariosis are those with profound and prolonged neutropenia and/or T-cell immunodeficiency [5, 47, 48] .
Among immunocompetent hosts, keratitis and onychomycosis are the most common infections [46] . In immunocompromised patients, the most common presentations include pneumonia, sinusitis and fungaemia with or without cutaneous lesions (50%e 58% of cases) [46, 47, 49] , with very high mortality in the setting of fungaemia (94% at 12 weeks) [48] . There have been outbreaks of fusarial keratitis in contact lens wearers (see Outbreaks) and peritonitis in patients receiving peritoneal dialysis [50] . Table 1 Emerging non-Aspergillus moulds highlighted in this review Scedosporium spp.
Scedosporium prolificans and members of the Scedosporium apiospermum species complex (which now includes fungi previously described as Pseudallescheria boydii) are the most common pathogens in this genus [51e53] . Among the S. apiospermum species complex, in addition to the more common S. apiospermum, Scedosporium aurantiacum and Scedosporium dehoogii have recently been described as human pathogens [51, 54, 55] . Because there are species-specific differences in virulence and antifungal susceptibility, identification of the causative agent to species level is essential.
In an Australian study of non-Aspergillus mould infection epidemiology, Scedosporium fungi comprised the largest proportion after the mucormycetes [5] . Risk factors for infection include chronic obstructive or suppurative lung disease, haematological malignancy, solid organ transplantation (SOT) or HSCT, corticosteroid use, neutropenia and DM [5,51e53] ; however a substantial proportion of infections affect hosts without apparent immune deficiency (22%e50%) [51, 56] . In immunocompetent patients, infection is seen particularly following trauma or inhalation associated with near drowning [5, 53, 57] .
In immunocompromised hosts, clinical presentation of S. prolificans and S. apiospermum complex are similar to other invasive mould infections with the exception of positive blood cultures for S. prolificans occurring in up to 50% of neutropenic patients [56] . Half of transplant recipients have disseminated disease at presentation with involvement of skin and central nervous system (CNS) [58] presenting with fever (90%), focal CNS symptoms (40%), appearance of rash (30%) and fungaemia (72%) [56, 59] . There is a very high mortality rate for disseminated scedosporiosis with additional predictors of poor prognosis being lack of neutrophil recovery and CNS infection [52] .
Acremonium spp.
This genus includes approximately 150 species, with only a few implicated as human pathogens [60] . Acremonium kiliense and Acremonium falciforme are the most common pathogens with Acremonium roseogriseum, Acremonium strictum, Acremonium patronii and Acremonium recifei also described as opportunistic pathogens [60] . These emerging pathogens mainly affect immunocompromised patients following HSCT, SOT or haematological malignancy [6, 61] .
In a recent review, two-thirds of cases were localized infections, and one-third were disseminated infections in immunocompromised hosts [60] . Classically following a penetrating skin injury, localized infections tend to appear as either subcutaneous nodules with discharging sinuses or less commonly as mycetomas. [62] . Onychomycosis, otomycosis, endophthalmitis and complications in burn patients have been described [63] and allergic fungal rhinosinusitis is well recognized [64] . Pneumonia, arthritis, osteomyelitis, endocarditis, meningitis, peritonitis and sepsis with fungaemia in immunocompromised patients have been reported [65, 66] . In addition, there are occasional reports of fungaemia in otherwise normal hosts with prosthetic material such as subclavian catheters, mitral valve replacements and pacemakers [67e69]. There was a notable outbreak of catheter-related Acremonium kiliense fungaemia among HSCT patients [70] (see Outbreak section).
Paecilomyces spp.
The Paecilomyces genus includes two main pathogenic species: Paecilomyces variotii and Paecilomyces lilacinus. Paecilomyces liliacinus has recently been reclassified as Purpureocillium lilacinus. [71] . The portal of entry of infection is often a break in the skin or an intravenous catheter [72] .
The most common clinical manifestations are oculomycosis and cutaneous and subcutaneous infections [73] ; however, there are increasing reports of clinically significant and serious infections affecting any body site [6] . Risk factors for invasive infection include not only leukaemia, SOT and HSCT [74, 75] but also human immunodeficiency virus/acquired immunodeficiency syndrome, DM and liver cirrhosis [73, 76] . In these patients, manifestations include pneumonia, sinusitis, osteomyelitis, disseminated infection and fungaemia [73] , with fungaemia and sinusitis being the most commonly reported. There have been uncommon reports of peritonitis in the context of continuous ambulatory peritoneal dialysis [77] and liver transplantation [78] , and an outbreak of P. lilacinus skin infection with some cases of dissemination in HSCT patients due to contaminated skin lotion [72] . A mortality rate of 14.3% for P. lilacinus was observed in a recent review of the literature [73] , which is generally lower than for other hyalohyphomycete infections.
Trichoderma spp.
Trichoderma spp. were previously thought to be non-pathogenic; however, Trichoderma longibrachiatum and Trichoderma citrinoviride have emerged as opportunistic pathogens in immunocompromised patients [79] . Likely sources of infection are non-sterile water sources and aerosols [80] . Fatal disseminated T. longibrachiatum infections have been described in patients with haematological malignancies and both SOT and HSCT [79, 81, 82] . The most common sites of isolation in human clinical specimens are the respiratory tract (40%), deep tissue (30%) and superficial tissues (26%) [83] . Deep pulmonary infection [84] , invasive sinusitis [85] and peritonitis in continuous ambulatory peritoneal dialysis patients have been reported [86] . There have been rare cases of endocarditis [5, 87] , brain abscess [88] and a case of fatal mediastinitis in a patient with congenital heart disease on continuous ambulatory peritoneal dialysis [89] .
Rasamsonia spp.
Previously known as Geosmithia spp., this genus has recently been renamed Rasamsonia [90] . These organisms may have been previously under-reported because they were frequently misidentified as Penicillium or Paecilomyces species [90] . Rasamsonia argillacea species complex is truly an emerging pathogen with increasing descriptions of pulmonary infection in those with chronic granulomatous disease and as a colonizing organism in patients with cystic fibrosis [43, 91] . The most common portal of entry is the respiratory tract and pulmonary infection can rapidly extend across tissue planes from lungs to adjacent ribs. Bone and CNS involvement can occur following dissemination from the lung [90] .
In at-risk groups as described above, dialogue with the diagnostic laboratory is critical because specific incubation conditions are required to recover this organism (see below).
Schizophyllum spp.
The basidiomycete Schizophyllum commune was first reported as a human pathogen causing onychomycosis in 1950 by Kligman [92] . Until recently, S. commune was thought to be a rare cause of human disease. However, there have been increasing reports of infection, with 93 cases being reported to date (Table 3) . Forty-three per cent of cases were of sinusitis, commonly allergic rhinosinusitis, 22% of cases were allergic bronchopulmonary mycosis, and overall 92% of cases involved the upper or lower respiratory tract. Extrapulmonary cases reported include a single case each of onychomycosis, meningitis and palatal ulceration, two cases of brain abscess and two of ocular infection. The majority of reports originate from Japan, Iran, USA and Austria, which may reflect increased awareness and reporting in these locations [93] . Although the two brain abscess cases were in mildly immunocompromised individuals (one with diabetes and the other taking corticosteroids), the majority of infections, especially sinusitis and allergic bronchopulmonary aspergillosis, are described in immunocompetent patients. Interestingly, a fatal case of empyema was described in an otherwise healthy patient [100] .
Phaeohyphomycetes
The Phaeohyphomycetes, cause of phaeohyphomycosis, are so named because they produce melanin resulting in dark pigmentation of their colonies, and are also known as melanized or dematiaceous fungi. Ubiquitous in the environment, there are over 100 species of fungi [104] .
Dematiaceous fungal infections generally result from inhalation or percutaneous inoculation of fungal spores through trauma. They tend to produce superficial infection in immunocompetent patients, but can readily disseminate and have the potential to cause deep infections in the immunocompromised [105, 106] . There are increasing reports of clinical infection (Fig. 1) , with some of the more common aetiological genera including Alternaria, Bipolaris, Cladophialophora and Exophiala [107] . Common presentations and risk groups are summarized in Table 4 . There is also an observed predisposition of phaeohyphomycetes, in particular Cladophialophora bantiana, to cause CNS infection in immunocompetent patients [117] .
Verruconis gallopava
Previously known as Ochroconis gallopava or Dactylaria gallopava, Verruconis gallopava has been encountered worldwide; however, there has been a predominance of reports from southeastern USA [118] . Environmental sources of Verruconis spp. include soil, decaying vegetable material [119, 120] , cave rocks [121] , thermal soils and hot springs [122] , coal waste piles and broiler house litter [123, 124] .
This fungus has emerged as an important pathogen, particularly in SOT recipients [5,125e127] and those with haematological malignancy undergoing chemotherapy [118, 128] (Table 5 ). Infections present in pulmonary and extrapulmonary sites including brain, spleen and skin [126e128,151] . Infection may be disseminated in immunocompromised hosts [5, 104] .
Outbreaks of non-Aspergillus moulds
There have been several notable outbreaks of non-Aspergillus moulds reported in the literature (Table 6 ) with an increasing number of these reports over time, particularly in 2014. Common precipitating factors include natural disasters and contamination of medical supplies. These outbreaks highlight the tendency for non- (14) Iran (7) Japan (4) Taiwan (1 Aspergillus moulds to cause infection in otherwise healthy individuals if the normal innate barriers to protection (e.g. skin) are breached. The increasing number of outbreaks may be related to increased awareness and surveillance but Vijaykumar et al. identify gaps in current practice around testing for reducing melanized mould contamination in pharmaceutical manufacturing [163] .
Advances in laboratory diagnostics
Clinical manifestations of non-Aspergillus mould infections are often non-specific, so timely, accurate detection of the causative agent is essential to inform the choice of antifungal therapy. Currently culture, and other conventional, diagnostic methods are still the cornerstone of diagnosis. Molecular methods to directly detect/identify mould pathogens in tissue and body fluids are increasingly used [164] .
Visualization of fungal structures allows assessment of their morphology but specificity is low for distinguishing non-Aspergillus hyaline moulds from Aspergillus and even between these and the Mucorales [165] . Immunohistochemical techniques such as in situ hybridization with a specific fluorescent antibody that binds to fungal elements in affected tissue may also aid diagnosis but their use has not been clinically validated. In one study, Fusarium was distinguished from Aspergillus elements in tissue sections with a 100% positive predictive value [166] .
Nucleic acid amplification techniques that employ either panfungal PCR assays (combined with DNA sequencing) or fungal species-specific assays may also be used to identify pathogens directly in tissue, blood, serum or sputum [164] . These methods yielded good sensitivity and specificity in small case series Species identification may be difficult using phenotypic methods because non-Aspergillus moulds may sporulate poorly, e.g. Apophysomyces and other genera within the Mucorales, and genera, including Fusarium and Scedosporium, species complexes. [164, 173, 174] . Fungal identification by molecular methods is largely reliant on DNA sequencing and comparative sequence analysis is now the reference standard for identification of filamentous fungi. The internal transcribed spacer (ITS) loci, and the 28S subunit of the rRNA gene are the most widely used targets for species identification of moulds [164] . The ITS regions are especially discriminatory and major gene repositories such as the GenBank database (www.ncbi.nlm.nih.gov) contain large numbers of sequences from this locus enabling ready comparison of sequences. However, alternate gene targets including the elongation factor 1a (EF1-a), RPB2 (which encodes the second largest RNA polymerase subunit gene), calmodulin and b-tubulin genes are also used, particularly for the identification of Scedosporium [53] and Fusarium [175, 176] . Sequencing of ITS is also insufficient to resolve species identity among many Mucorales; either the D1eD2 regions of the 28S rRNA gene is sequenced and if unsuccessful, cloning of PCR products to identify species is required [177] . Of note, current public gene repositories are not censored and errors in archived fungal sequences are estimated at 14%e20% [178] .
Currently there are no rapid biomarker tests specific to nonAspergillus mould infections. The presence of Aspergillus HSCT, haematopoietic stem cell transplantation. galactomannan, a cell wall polysaccharide specific for Aspergillus spp., in serum and broncholalveolar lavage fluid may hence assist in differentiating aspergillosis from other hyaline moulds. However, false-positive results occur and results should be interpreted in conjunction with clinical and radiological findings [179] . 1,3-b-D glucan, a cell wall constituent of many fungi, may also be detectable in the serum of patients with non-Aspergillus mould infection with the exception of mucormycosis [180] . However, outside the outbreak of fungal meningitis in the USA in 2012, where it was applied to CSF with good sensitivity and specificity for infection, there is little experience in using this test to diagnose non-Aspergillus mould infections [181] .
Conclusion
Non-Aspergillus mould infections are emerging both in immunocompromised and immunocompetent patients, presenting in many and varying ways. Notably, outbreaks of infections with these moulds are increasingly reported, often healthcare-associated or in the aftermath of trauma sustained in natural disasters. There are no specific non-culture based tests available and diagnosis relies upon visualization of hyphae in tissue and further identification by either culture or molecular testing. However, public gene repositories contain errors in up to 20% of archived fungal sequences. Agendas for future research include developing better surveillance and diagnostic tests to help with earlier recognition of infection and potential sources of infection as well as improving archived sequence accuracy.
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